
Kina Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: GLP-1 weight care alongside HRT, from board-certified physicians
Kina scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $199/mo ongoing
Tirzepatide
Price checked on Kina’s site,
What the monthly price covers
Medication
Included
Provider visits
Billed separately
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Its GLP-1 program provides compounded semaglutide and tirzepatide from $199/month after a $169 first month (the $25 physician consultation fee is covered; $0 membership), prescribed and monitored by board-certified physicians at Arora Health & Aesthetics. It carries verifiable LegitScript certification, is FSA/HSA eligible, ships free, and is cancel-anytime. Compounded medications are not FDA-approved; the pharmacy is not named.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Kina
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Kina at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $229/mo (+ consult fee) (Ongoing monthly price; same at every dose. Care starts at $169 for the first month.)
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Kina
Each dimension is scored algorithmically from Kina’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.0/10At $229/mo (+ consult fee), Kina runs about 28% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $169.
Effectiveness25%
8.9/10Kina offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.0/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
8.1/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.3/10Kina's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.7/10Kina provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Kina review
Last checked November 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$279/mo across 4 dose/plan tiers (checked July 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Kina
We walked Kina’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a brief ~2-minute intake about your symptoms and goals.
- 2A licensed clinician reviews it and prescribes a plan if appropriate.
- 3Receive free shipping from a licensed pharmacy with ongoing support.
- $169 first-month price displayed prominently before any intake.
- States 'No memberships, no hidden fees,' 'No insurance required,' and 'FSA/HSA eligible.'
- Only 'Cancel anytime' is mentioned; no specific refund terms provided.
- Free shipping stated repeatedly.
- Prescribing done by clinicians at Arora Health & Aesthetics, licensed in your state.
GLP-1 medications Kina offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Kina offers
Beyond GLP-1s, Kina also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$199/month standing, $169 for a first month. A $25 physician consultation fee is covered, not added.
Ongoing monthly price; same at every dose. Care starts at $169 for the first month.
Ongoing monthly price; same at every dose. Care starts at $169 for the first month.
Ready to get started?
Plans and promotions change often, so check Kina's current pricing and active discounts before you decide.
What we like
- Menopause-specialized care: GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- Verifiable LegitScript certification (seal ID 50917967)
- GLP-1 from $199/month ($169 first month) with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Watch-outs
- Compounded medications are not FDA-approved and are not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Built for women going through menopause, so less tailored if that is not your situation
- The $169 first-month price rises to $199–$279 a month from month two, depending on the medication and form
- The compounding pharmacy partner is not named, and the full list of served states is not published
Is Kina worth it?
Kina's whole pitch comes down to this: GLP-1 weight care alongside HRT, from board-certified physicians. New patients start at $169/month for the first month, but the price steps up to $229/month (+ consult fee) once that window ends, so treat the headline number as an intro offer, not the standing rate. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
Beyond the medication itself, Kina is LegitScript-certified. It also takes HSA/FSA payment and is staffed by board-certified clinicians.
How much Kina costs
- Compounded semaglutide starts at $169 for the first month, then $199/month after that, for that option.
- Compounded tirzepatide is currently $169/month on an intro offer, regularly $249/month, if you go that route.
Because Kina's headline figure is a price plus a consult fee, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Kina with the month-to-month prices of the alternatives below instead.
RxSpan MD (about $249/month) is one of the closest alternatives to weigh Kina against.
Medications: what Kina prescribes
Kina prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Kina is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Kina's intro price of $169 takes some of the cost out of the first month; after that, budget from $229/month (+ consult fee) and check how that figure is billed before you commit. To see Kina against the wider field, use the full list of semaglutide providers we rank; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Kina scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Kina?
From $229/mo (+ consult fee). See current pricing and start your free consultation.
Kina might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Kina vs…
Kina scores7.8/10
Side-by-side pricing, medications and scores. Pick a matchup.
Kina vs Amazon One Medical
Amazon One Medical scores 8.5/10

Kina vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Kina review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Kina's current pricing
Plans from $229/mo (+ consult fee). Start your free consultation to check eligibility and today's price.